Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Pennant Group
PNTG
Pennant Group
Medicare Cuts, Workforce Strain Will Test Operations But Spark Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
10 Aug 25
Updated
10 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$28.00
6.6% undervalued
intrinsic discount
10 Aug
US$26.15
Loading
1Y
-11.7%
7D
18.0%
Author's Valuation
US$28.0
6.6% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$28.0
6.6% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-3m
1b
2016
2018
2020
2022
2024
2025
2026
2028
Revenue US$1.3b
Earnings US$70.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
12.95%
Healthcare Services revenue growth rate
0.29%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$70.76m
Earnings '28
x
24.94x
PE Ratio '28
=
US$1.76b
Market Cap '28
US$1.76b
Market Cap '28
/
51.77m
No. shares '28
=
US$34.08
Share Price '28
US$34.08
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$28.00
Fair Value '25
